Russian Heart Failure Journal 2008year Multiple use of levosimendan in a female patient with acute decompensated CHF


To access this material please log in or register

Register Authorize
2008/

Multiple use of levosimendan in a female patient with acute decompensated CHF

Tereshchenko S.N., Golubev A.V., Kositsyna I.V., Strakhova N.S., Uskach T.M.

Keywords:

DOI:

    1.    Белоусов Ю. Б., Ерофеева С. Б. Левосимендан – новый препарат для лечения сердечной недостаточности. Фарматека. 2007:8 (86), интернет-ресурс http://www.pharmateca.ru / cgi-bin / statyi. pl? sid=127&mid=1085056570&magid=13
    2.    Thackray S., Easthaugh J., Freemantle N., Cleland J.G. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis.. Eur J Heart Fail. 2002;4 (4):515–529.
    3.    Stevenson L. W. Clinical Use of Inotropic Therapy for Heart Failure: Looking Backward or Forward? Part I: Inotropic Infusions During Hospitalization. Circulation. 2003;108 (3):367–372.
    4.    Cuffe M. S., Califf R. M., Adams K. F. Jr et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287 (12):1541–1547.
    5.    Терещенко С. Н. Новый взгляд на инотропные препараты в лечении сердечной недостаточности. Сердечная недостаточность. 2001;2 (1):8–10.
    6.    Haikala H., Nissinen E., Etemadzadeh E. et al. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol. 1995;25 (5):794–801.
    7.    Findlow D., Doyle E. Congenital heart disease in adults. Br J Anaesth. 1997;78 (4):416–430.

To access this material please log in or register

Register Authorize
Ru En